We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
ERNA

Price
0.21
Stock movement up
+0.02 (9.10%)
Company name
Eterna Therapeutics Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
10.72M
Ent value
59.56M
Price/Sales
17.92
Price/Book
-
Div yield
-
Div growth
-
Growth years
-
FCF payout
-0.09%
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-90.77%
3 year return
-81.97%
5 year return
-66.94%
10 year return
-57.40%
Last updated: 2025-04-14

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

DIVIDENDS

ERNA does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales17.92
Price to Book-
EV to Sales99.61

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count51.37M
EPS (TTM)-8.31
FCF per share (TTM)-3.21

Income statement

Loading...
Income statement data
Revenue (TTM)598.00K
Gross profit (TTM)-586.00K
Operating income (TTM)-18.74M
Net income (TTM)-44.93M
EPS (TTM)-8.31
EPS (1y forward)-

Margins

Loading...
Margins data
Gross margin (TTM)-97.99%
Operating margin (TTM)-3134.11%
Profit margin (TTM)-7513.88%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash4.26M
Net receivables187.00K
Total current assets4.73M
Goodwill2.04M
Intangible assets0.00
Property, plant and equipment824.00K
Total assets7.72M
Accounts payable2.19M
Short/Current long term debt33.55M
Total current liabilities9.95M
Total liabilities53.11M
Shareholder's equity-45.39M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-16.95M
Capital expenditures (TTM)388.00K
Free cash flow (TTM)-17.34M
Dividends paid (TTM)16.00K

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-
Return on Assets-582.18%
Return on Invested Capital341.57%
Cash Return on Invested Capital131.81%

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open0.19
Daily high0.21
Daily low0.18
Daily Volume108K
All-time high22250.00
1y analyst estimate3.00
Beta7.77
EPS (TTM)-8.31
Dividend per share-
Ex-div date-
Next earnings date12 May 2025

Downside potential

Loading...
Downside potential data
ERNAS&P500
Current price drop from All-time high-100.00%-12.04%
Highest price drop-100.00%-56.47%
Date of highest drop10 Apr 20259 Mar 2009
Avg drop from high-83.99%-11.07%
Avg time to new high301 days12 days
Max time to new high7968 days1805 days

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
ERNA (Eterna Therapeutics Inc) company logo
Marketcap
10.72M
Marketcap category
Small-cap
Description
Eterna Therapeutics Inc., a life science company, provides mRNA cell engineering technologies. Its technologies include mRNA cell reprogramming and gene editing; NoveSlice and UltraSlice gene-editing proteins; and the ToRNAdo mRNA delivery system. The company has a license agreement with Factor Bioscience Limited. Eterna Therapeutics Inc. was founded in 2018 and is based in Cambridge, Massachusetts.
Employees
8
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...